CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Arnica montana +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01164644
NCT01164644N/ACompleted
CompareCT.gov

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

University of Wisconsin, Madison·interventional·Posted Jul 16, 2010·Updated May 17, 2017

In Brief

A clinical study evaluating Arnica montana and Placebo for Ecchymosis. Completed, enrolled 28 participants across 1 site.

Detailed Summary

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surgeons throughout the world, although there is no study proving its benefit after rhinoplasty surgery. The purpose of the research is to see if Arnica montana will reduce the amount of bruising and the intensity of the bruising after surgery. Photographs of the subject's face will be taken and used to analyze bruising after rhinoplasty surgery in subjects who receive Arnica montana and compare them to photographs of subjects who take a placebo (sugar pill).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEcchymosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 16, 2010
Enrollment StartJun 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 16.0 years ago

Interventions

Arnica montanadrug

Subjects will take twelve pills by mouth three times a day over four days.

Placebodrug

Subjects will take twelve pills by mouth three times a day over four days.